VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

live attenuated Brucella suis strain S105 vaccine
Vaccine Information
  • Vaccine Name: live attenuated Brucella suis strain S105 vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009066
  • Type: Live attenuated vaccine
  • Status: Research
  • Host Species for Licensed Use: Sheep
  • Host Species as Laboratory Animal Model: Mus musculus; guinea pig
  • Preparation: Oral vaccine formulation of the mutant strain S105. (Zhao et al, 1989)
  • Description: A mutant strain S105 was selected from Brucella suis strain 2 after chemical mutagenesis with diethyl sulphate (DES) to reduce residual virulence. Efficacy: Strain S105 was as effective as the parent strain 2 in stimulating protective immunity to Brucella melitensis in sheep. Immune response: Not reported explicitly; implied protective immunity stimulation in sheep. (Zhao et al, 1989)
Host Response
References
Zhao et al, 1989: Zhao WR, Wendoso, Hasi, Qin YX, Weng W, Lu SL. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis. Journal of medical microbiology. 1989 Oct; 30(2); 143-8. [PubMed: 2795638].